EBM Technologies (8409) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 商之器

EBM Technologies (8409) reported revenue of NT$29.5 million for Oct 2026, +184.8% year on year and -6.0% from the previous month. Revenue for Jan–Oct 2026 was NT$184.3 million (+2.0% year on year).

In Oct 2026, it ranked No. 120 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$78.7 million24/10Nov 2024 NT$13.6 millionDec 2024 NT$85.8 millionJan 2025 NT$4.7 millionFeb 2025 NT$8.2 million25/02Mar 2025 NT$10.5 millionApr 2025 NT$10.5 millionMay 2025 NT$11.7 millionJun 2025 NT$11.3 million25/06Jul 2025 NT$19.4 millionAug 2025 NT$15.1 millionSep 2025 NT$79.1 millionOct 2025 NT$10.4 million25/10Nov 2025 NT$11.3 millionDec 2025 NT$61.1 millionJan 2026 NT$18.7 millionFeb 2026 NT$16.8 million26/02Mar 2026 NT$16.2 millionApr 2026 NT$8.5 millionMay 2026 NT$13.6 millionJun 2026 NT$13.6 million26/06Jul 2026 NT$15 millionAug 2026 NT$21 millionSep 2026 NT$31.4 millionOct 2026 NT$29.5 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$29.5 million+184.8%-6.0%
Sep 2026NT$31.4 million-60.3%+50.0%
Aug 2026NT$21 million+39.2%+39.5%
Jul 2026NT$15 million-22.7%+10.2%
Jun 2026NT$13.6 million+20.9%+0.0%
May 2026NT$13.6 million+16.5%+61.1%
Apr 2026NT$8.5 million-19.3%-47.7%
Mar 2026NT$16.2 million+54.6%-3.6%
Feb 2026NT$16.8 million+105.6%-10.5%
Jan 2026NT$18.7 million+300.6%-69.3%
Dec 2025NT$61.1 million-28.8%+440.7%
Nov 2025NT$11.3 million-16.8%+8.9%
Oct 2025NT$10.4 million-86.8%-86.9%
Sep 2025NT$79.1 million+580.3%+425.3%
Aug 2025NT$15.1 million+35.0%-22.5%
Jul 2025NT$19.4 million-23.5%+72.5%
Jun 2025NT$11.3 million+3.3%-3.6%
May 2025NT$11.7 million+22.5%+11.5%
Apr 2025NT$10.5 million+43.0%+0.3%
Mar 2025NT$10.5 million-1.8%+28.3%
Feb 2025NT$8.2 million+8.4%+74.4%
Jan 2025NT$4.7 million-46.5%-94.6%
Dec 2024NT$85.8 million+28.4%+531.6%
Nov 2024NT$13.6 million-28.5%-82.8%
Oct 2024NT$78.7 million+579.5%+576.7%

Jan–Oct 2026 cumulative: NT$184.3 million (+2.0% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: EBM Technologies vs PEC / EBM Technologies vs Lotus Pharm / EBM Technologies vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

本月驗收結案之專案較上月增加。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16